drugset / Trial / NCT00615797

Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea

NCT00615797

RandomizedParallel-groupDouble-blindTreatment

Summary

Children are at risk of developing an involuntary movement disorder after streptococcal throat infections. Not all children are affected and the severity is individually variable. Affected children have alteration in their behaviour and mood and can become quite compromised in their activities of daily living. The condition is believed to be related to the body having an over efficient immune response to the infection and some of the antibodies made in response to the infection also "attack" centres in the brain controlling movement and mood. Treating these children with immunoglobulins, which "mop up" the antibodies may reverse or improve affected children. This study hopes to clarify this.

Timeline

Start
2002-05
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Immune Globulin Intravenous (Human) Protein / enzyme biologic 2 g/kg Intravenous
Comparator Haloperidol Other / unclassified 0.05 mg/kg Oral
Comparator Penicillin V Small molecule 250 mg Oral
Comparator Penicillin V Small molecule 500 mg Oral